The complexity of the disease has made ventilator use challenging. Treatment of COVID-19 has been a medical puzzle for front-line doctors largely learning about the disease in real-time without proven ...
As the COVID-19 pandemic continues, increasing the number of patients suffering from respiratory conditions and requiring respiratory support, softFlow offers clinicians across the continuum of care ...
High-flow nasal cannula therapy is as safe and efficacious as conventional modes of noninvasive ventilation (NIV) in preterm infants, according to a meta-analysis published online August 17 and in the ...
Please provide your email address to receive an email when new articles are posted on . Treating bronchiolitis outside the ICU with weight-based high-flow nasal cannula protocols reduced ICU ...
Please provide your email address to receive an email when new articles are posted on . The addition of high-flow nasal cannula to long-term oxygen therapy may ...
EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® ...
According to Coherent Market Insights, the global nasal cannula market is estimated to account for US$ 10,491.1 mn in terms of value by the end of 2028. A nasal cannula is a medical device that ...
Use of high-flow oxygen was associated with less of a need for mechanical ventilation and a shorter time to recovery compared with conventional oxygen therapy in patients with severe COVID-19, a ...
In this cohort of 18 children's hospitals, transitioning to a weight-based HFNC protocol was associated with a 6.1% decrease per year in ICU admission, a 1.5% reduction per year in use of noninvasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback